Education
About Us
Working with TipRanks
Follow Us
Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
Total Valuation
Anthera Pharmaceuticals has a market cap or net worth of $2.62K. The enterprise value is ―.
Market Cap$2.62K
Enterprise Value―
Share Statistics
Anthera Pharmaceuticals has 26,179,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding26,179,000
Owned by Insiders―
Owned by Institutions0.04%
Financial Efficiency
Anthera Pharmaceuticals’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count21
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Anthera Pharmaceuticals is 0.00. Anthera Pharmaceuticals’s PEG ratio is ―.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Anthera Pharmaceuticals had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -31.95M and capital expenditures 0.00, giving a free cash flow of -31.95M billion.
Operating Cash Flow-31.95M
Free Cash Flow-31.95M
Free Cash Flow per Share-1.22
Dividends & Yields
Anthera Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-41.28
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)23.88K
Important Dates
Anthera Pharmaceuticals upcoming earnings date is Mar 5, 2018, TBA Not Confirmed.
Last Earnings DateNov 6, 2017
Next Earnings DateMar 5, 2018
Ex-Dividend Date―
Financial Position
Anthera Pharmaceuticals as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Anthera Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Anthera Pharmaceuticals EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Anthera Pharmaceuticals has $8.09M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$8.09M billion.
Cash & Marketable Securities$8.09M
Total Debt$0.00
Net Cash-$8.09M
Net Cash Per Share-$0.31
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Anthera Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―